Human-induced pluripotent stem cell (hiPSC)-derived hepatocytes are anticipated as important surrogates for primary human hepatocytes in applications ranging from basic research to drug discovery and regenerative medicine. Although methods for differentiating hepatocyte-like cells (HLCs) from hiPSCs have developed remarkably, the limited yield of fully functional HLCs is still a major obstacle to their utility. A three-dimensional (3D) culture environment could improve the in vitro hepatic maturation of HLCs. Here we compare 3D hydrogel models of hiPSC-derived HLCs in agarose microwells (3D Petri Dish; 3DPD), nanofibrillar cellulose hydrogels (Growdex; 3DNFC), or animal extracellular matrix-based hydrogels (3D Matrigel; 3DMG). In all the tested 3D biomaterial systems, HLCs formed aggregates. In comparison with two-dimensional monolayer culture, 3DPD and 3DMG models showed both phenotypic and functional enhancement in HLCs over 2.5 weeks of 3D culture. Specifically, we found higher hepatocyte-specific gene expression levels and enhanced cytochrome P450 functions. Our work suggests that transferring HLCs into 3D hydrogel systems can expedite the hepatic maturation of HLCs irrespective of the biochemical nature of the 3D hydrogel. Both plant-based nonembedding and animal-based embedding 3D hydrogel models enhanced the maturation.
Get full access to this article
View all access options for this article.
References
1.
AdenD.P., FogelA., PlotkinS., DamjanovI., and KnowlesB.B.Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature, 282, 615, 1979.
2.
AnderssonT.B., KanebrattK.P., and KennaJ.G.The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human. Expert Opin Drug Metab Toxicol, 8, 909, 2012.
3.
JiaL., and LiuX.The conduct of drug metabolism studies considered good practice (II): in vitro experiments. Curr Drug Metab, 8, 822, 2007.
4.
GeretsH.H., et al.Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol, 28, 69, 2012.
5.
Dias-da-SilvaD., ArboM.D., ValenteM.J., BastosM.L., and CarmoH.Hepatotoxicity of piperazine designer drugs: comparison of different in vitro models. Toxicol In Vitro, 29, 987, 2015.
6.
SusukidaT., et al.Establishment of a drug-induced, bile acid-dependent hepatotoxicity model using HepaRG cells. J Pharm Sci, 105, 1550, 2016.
7.
KanebrattK.P., and AnderssonT.B.Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies. Drug Metab Dispos, 36, 1444, 2008.
8.
GridelliB., et al.Efficient human fetal liver cell isolation protocol based on vascular perfusion for liver cell-based therapy and case report on cell transplantation. Liver Transplant, 18, 226, 2012.
9.
YusaK., et al.Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature, 478, 391, 2011.
10.
ShlomaiA., et al.Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems. Proc Natl Acad Sci U S A, 111, 12193, 2014.
11.
CayoM.A., et al.JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia. Hepatology, 56, 2163, 2012.
12.
GodoyP., et al.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol, 87, 1315, 2013.
13.
RamasamyT.S., YuJ.S., SeldenC., HodgsonH., and CuiW.Application of three-dimensional culture conditions to human embryonic stem cell-derived definitive endoderm cells enhances hepatocyte differentiation and functionality. Tissue Eng Part A, 19, 360, 2013.
14.
GieseckR.L.3rd, et al.Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture. PLoS One, 9, e86372, 2014.
15.
AderM., and TanakaE.M.Modeling human development in 3D culture. Curr Opin Cell Biol, 31, 23, 2014.
16.
DuC., NarayananK., LeongM.F., and WanA.C.Induced pluripotent stem cell-derived hepatocytes and endothelial cells in multi-component hydrogel fibers for liver tissue engineering. Biomaterials, 35, 6006, 2014.
17.
BierwolfJ., et al.Primary rat hepatocyte culture on 3D nanofibrous polymer scaffolds for toxicology and pharmaceutical research. Biotechnol Bioeng, 108, 141, 2011.
18.
TakebeT., et al.Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature, 499, 481, 2013.
19.
ChangT.T., and Hughes-FulfordM.Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes. Tissue Eng Part A, 15, 559, 2009.
20.
OshikataA., MatsushitaT., and UeokaR.Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells. J Biosci Bioeng, 111, 590, 2011.
YangZ., et al.In vitro and in vivo characterization of silk fibroin/gelatin composite scaffolds for liver tissue engineering. J Dig Dis, 13, 168, 2012.
23.
NagamotoY., et al.The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets. Biomaterials, 33, 4526, 2012.
24.
McCrackenK.W., HowellJ.C., WellsJ.M., and SpenceJ.R.Generating human intestinal tissue from pluripotent stem cells in vitro. Nat Protoc, 6, 1920, 2011.
25.
SivertssonL., SynnergrenJ., JensenJ., BjorquistP., and Ingelman-SundbergM.Hepatic differentiation and maturation of human embryonic stem cells cultured in a perfused three-dimensional bioreactor. Stem Cells Dev, 22, 581, 2013.
26.
TakayamaK., et al.3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing. Biomaterials, 34, 1781, 2013.
27.
TouboulT., et al.Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology, 51, 1754, 2010.
28.
DeLaForestA., et al.HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development, 138, 4143, 2011.
29.
HayD.C., et al.Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci U S A, 105, 12301, 2008.
30.
HughesC.S., PostovitL.M., and LajoieG.A.Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics, 10, 1886, 2010.
31.
KleinmanH.K., et al.Basement membrane complexes with biological activity. Biochemistry, 25, 312, 1986.
32.
Ben-Ze'evA., RobinsonG.S., BucherN.L., and FarmerS.R.Cell-cell and cell-matrix interactions differentially regulate the expression of hepatic and cytoskeletal genes in primary cultures of rat hepatocytes. Proc Natl Acad Sci U S A, 85, 2161, 1988.
33.
MogheP.V., et al.Culture matrix configuration and composition in the maintenance of hepatocyte polarity and function. Biomaterials, 17, 373, 1996.
34.
SidhuJ.S., LiuF., and OmiecinskiC.J.Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. Exp Cell Res, 292, 252, 2004.
35.
PageJ.L., et al.Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture. Toxicol Sci, 97, 384, 2007.
36.
Gross-SteinmeyerK., et al.Influence of Matrigel-overlay on constitutive and inducible expression of nine genes encoding drug-metabolizing enzymes in primary human hepatocytes. Xenobiotica, 35, 419, 2005.
37.
BergerD.R., WareB.R., DavidsonM.D., AllsupS.R., and KhetaniS.R.Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell-cell interactions in vitro. Hepatology, 61, 1370, 2015.
38.
ChengX., et al.Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. Cell Stem Cell, 10, 371, 2012.
39.
JiangH.L., et al.Roles of spheroid formation of hepatocytes in liver tissue engineering. Int J Stem Cells, 3, 69, 2010.
40.
DeanD.M., NapolitanoA.P., YoussefJ., and MorganJ.R.Rods, tori, and honeycombs: the directed self-assembly of microtissues with prescribed microscale geometries. FASEB J, 21, 4005, 2007.
41.
KlemmD., et al.Nanocelluloses: a new family of nature-based materials. Angew Chem Int Ed Engl, 50, 5438, 2011.
42.
MalinenM.M., et al.Differentiation of liver progenitor cell line to functional organotypic cultures in 3D nanofibrillar cellulose and hyaluronan-gelatin hydrogels. Biomaterials, 35, 5110, 2014.
43.
TrokovicR., WeltnerJ., and OtonkoskiT.Generation of iPSC line HEL47.2 from healthy human adult fibroblasts. Stem Cell Res, 15, 263, 2015.
44.
XuC., et al.Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol, 19, 971, 2001.
45.
MalinenM.M., PalokangasH., YliperttulaM., and UrttiA.Peptide nanofiber hydrogel induces formation of bile canaliculi structures in three-dimensional hepatic cell culture. Tissue Eng Part A, 18, 2418, 2012.
46.
SiegfriedG., KhatibA.M., BenjannetS., ChretienM., and SeidahN.G.The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity. Cancer Res, 63, 1458, 2003.
47.
LivakK.J., and SchmittgenT.D.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods, 25, 402, 2001.
48.
TolonenA., PetsaloA., TurpeinenM., UusitaloJ., and PelkonenO.In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies. J Mass Spectrom, 42, 960, 2007.
49.
KublbeckJ., et al.Genetically modified Caco-2 cells with improved cytochrome P450 metabolic capacity. J Pharm Sci, 105, 941949, 2016.
50.
ShanJ., et al.Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol, 9, 514, 2013.
51.
PaakkoM., et al.Enzymatic hydrolysis combined with mechanical shearing and high-pressure homogenization for nanoscale cellulose fibrils and strong gels. Biomacromolecules, 8, 1934, 2007.
52.
MallannaS.K., and DuncanS.A.Differentiation of hepatocytes from pluripotent stem cells. Curr Protoc Stem Cell Biol, 26, Unit 1G 4, 2013.
53.
WuF.J., FriendJ.R., RemmelR.P., CerraF.B., and HuW.S.Enhanced cytochrome P450 IA1 activity of self-assembled rat hepatocyte spheroids. Cell Transplant, 8, 233, 1999.
54.
GaskellH., SharmaP., ColleyH.E., MurdochC., and WebbS.D.Characterization of a functional C3A liver spheroid model. Toxicol Res, 2016; DOI: 10.1039/c6tx00101g.
55.
MehtaG., HsiaoA.Y., IngramM., LukerG.D., and TakayamaS.Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Controlled Release, 164, 192, 2012.
56.
VosoughM., et al.Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev, 22, 2693, 2013.
57.
TanimizuN., MiyajimaA., and MostovK.E.Liver progenitor cells develop cholangiocyte-type epithelial polarity in three-dimensional culture. Mol Biol Cell, 18, 1472, 2007.
58.
Miron-MendozaM., SeemannJ., and GrinnellF.The differential regulation of cell motile activity through matrix stiffness and porosity in three dimensional collagen matrices. Biomaterials, 31, 6425, 2010.
59.
ZamanM.H., et al.Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci U S A, 103, 10889, 2006.
60.
SchraderJ., et al.Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology, 53, 1192, 2011.
61.
BrandlF., SommerF., and GoepferichA.Rational design of hydrogels for tissue engineering: impact of physical factors on cell behavior. Biomaterials, 28, 134, 2007.
62.
TakayamaK., et al.Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4alpha transduction. Mol Ther, 20, 127, 2012.
63.
WangL., et al.Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics. Drug Metab Dispos, 43, 367, 2015.
64.
BaharvandH., HashemiS.M., Kazemi AshtianiS., and FarrokhiA.Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int J Dev Biol, 50, 645, 2006.
65.
GhoshehN., et al.Highly synchronized expression of lineage-specific genes during in vitro hepatic differentiation of human pluripotent stem cell lines. Stem Cells Int, 2016, 22, 2016.
66.
CameronK., et al.Recombinant laminins drive the differentiation and self-organization of hESC-derived hepatocytes. Stem Cell Reports, 5, 1250, 2015.
67.
McClellandR., WauthierE., UronisJ., and ReidL.Gradients in the liver's extracellular matrix chemistry from periportal to pericentral zones: influence on human hepatic progenitors. Tissue Eng Part A, 14, 59, 2008.
68.
ZangerU.M., and SchwabM.Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther, 138, 103, 2013.
69.
ZhuS., et al.Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature, 508, 93, 2014.
70.
LiL., LiD., HeywardS., and WangH.Transcriptional regulation of CYP2B6 expression by hepatocyte nuclear factor 3beta in human liver cells. PLoS One, 11, e0150587, 2016.
71.
BarthC.A., and SchwarzL.R.Transcellular transport of fluorescein in hepatocyte monolayers: evidence for functional polarity of cells in culture. Proc Natl Acad Sci U S A, 79, 4985, 1982.
72.
ToivonenS., et al.Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines. Stem Cells Transl Med, 2, 83, 2013.
73.
KyttalaA., et al.Genetic variability overrides the impact of parental cell type and determines iPSC differentiation potential. Stem Cell Rep, 6, 200, 2016.
74.
KajiwaraM., et al.Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A, 109, 12538, 2012.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
